US Stock MarketDetailed Quotes

BRTH Breathe BioMedical

Watchlist

0.000
0.0000.00%

Close Nov 29 09:30 ET

0Market Cap0.00P/E (TTM)

Breathe BioMedical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(FY)Dec 31, 2021

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

164.61%3.53M

75.40%8.9M

1.33M

11.41%5.07M

4.55M

Selling and administrative expenses

338.18%2.85M

101.89%6.7M

--650.6K

2.67%3.32M

--3.23M

-Selling and marketing expense

-99.27%89

-4.89%61.61K

--12.23K

-58.51%64.77K

--156.11K

-General and administrative expense

346.55%2.85M

104.02%6.64M

--638.37K

5.78%3.25M

--3.08M

Research and development costs

-9.34%571.35K

14.61%2.09M

--630.21K

13.91%1.82M

--1.6M

Depreciation amortization depletion

43.18%132.85K

47.13%383.26K

--92.79K

18.06%260.48K

--220.63K

-Depreciation and amortization

43.18%132.85K

47.13%383.26K

--92.79K

18.06%260.48K

--220.63K

Other operating expenses

35.41%-25.76K

17.18%-271.5K

---39.87K

34.29%-327.83K

---498.91K

Operating profit

-164.61%-3.53M

-75.40%-8.9M

-1.33M

-11.41%-5.07M

-4.55M

Net non-operating interest income expense

-323.87%-10.6K

-211.55%-16.15K

4.73K

19.46%14.48K

12.12K

Total other finance cost

323.87%10.6K

211.55%16.15K

---4.73K

-19.46%-14.48K

---12.12K

Other net income (expense)

18.76%203.85K

-7.82%555K

171.65K

5.27%602.07K

571.95K

Gain on sale of security

16.92%5.6K

-166.07%-4.27K

--4.79K

-53.24%6.46K

--13.82K

Other non- operating income (expenses)

18.81%198.25K

-6.10%559.27K

--166.86K

6.71%595.6K

--558.13K

Income before tax

-188.25%-3.34M

-87.57%-8.36M

-1.16M

-12.28%-4.46M

-3.97M

Income tax

Net income

-188.25%-3.34M

-87.57%-8.36M

-1.16M

-12.28%-4.46M

-3.97M

Net income continuous Operations

-188.25%-3.34M

-87.57%-8.36M

---1.16M

-12.28%-4.46M

---3.97M

Minority interest income

Net income attributable to the parent company

-188.25%-3.34M

-87.57%-8.36M

-1.16M

-12.28%-4.46M

-3.97M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-188.25%-3.34M

-87.57%-8.36M

-1.16M

-12.28%-4.46M

-3.97M

Basic earnings per share

-188.25%-0.3056

-87.57%-0.7661

-0.106

-12.28%-0.4085

-0.3638

Diluted earnings per share

-188.25%-0.3056

-87.57%-0.7661

-0.106

-12.28%-0.4085

-0.3638

Dividend per share

Currency Unit

CAD

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(FY)Dec 31, 2021
Total revenue	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	164.61%3.53M	75.40%8.9M	1.33M	11.41%5.07M	4.55M
Selling and administrative expenses	338.18%2.85M	101.89%6.7M	--650.6K	2.67%3.32M	--3.23M
-Selling and marketing expense	-99.27%89	-4.89%61.61K	--12.23K	-58.51%64.77K	--156.11K
-General and administrative expense	346.55%2.85M	104.02%6.64M	--638.37K	5.78%3.25M	--3.08M
Research and development costs	-9.34%571.35K	14.61%2.09M	--630.21K	13.91%1.82M	--1.6M
Depreciation amortization depletion	43.18%132.85K	47.13%383.26K	--92.79K	18.06%260.48K	--220.63K
-Depreciation and amortization	43.18%132.85K	47.13%383.26K	--92.79K	18.06%260.48K	--220.63K
Other operating expenses	35.41%-25.76K	17.18%-271.5K	---39.87K	34.29%-327.83K	---498.91K
Operating profit	-164.61%-3.53M	-75.40%-8.9M	-1.33M	-11.41%-5.07M	-4.55M
Net non-operating interest income expense	-323.87%-10.6K	-211.55%-16.15K	4.73K	19.46%14.48K	12.12K
Total other finance cost	323.87%10.6K	211.55%16.15K	---4.73K	-19.46%-14.48K	---12.12K
Other net income (expense)	18.76%203.85K	-7.82%555K	171.65K	5.27%602.07K	571.95K
Gain on sale of security	16.92%5.6K	-166.07%-4.27K	--4.79K	-53.24%6.46K	--13.82K
Other non- operating income (expenses)	18.81%198.25K	-6.10%559.27K	--166.86K	6.71%595.6K	--558.13K
Income before tax	-188.25%-3.34M	-87.57%-8.36M	-1.16M	-12.28%-4.46M	-3.97M
Income tax	0	0	0	0	0
Net income	-188.25%-3.34M	-87.57%-8.36M	-1.16M	-12.28%-4.46M	-3.97M
Net income continuous Operations	-188.25%-3.34M	-87.57%-8.36M	---1.16M	-12.28%-4.46M	---3.97M
Minority interest income
Net income attributable to the parent company	-188.25%-3.34M	-87.57%-8.36M	-1.16M	-12.28%-4.46M	-3.97M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-188.25%-3.34M	-87.57%-8.36M	-1.16M	-12.28%-4.46M	-3.97M
Basic earnings per share	-188.25%-0.3056	-87.57%-0.7661	-0.106	-12.28%-0.4085	-0.3638
Diluted earnings per share	-188.25%-0.3056	-87.57%-0.7661	-0.106	-12.28%-0.4085	-0.3638
Dividend per share
Currency Unit	CAD	CAD	CAD	CAD	CAD

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data